tiprankstipranks
Trxade Group (MEDS)
NASDAQ:MEDS

Trxade Group (MEDS) Stock Forecast & Price Target

132 Followers
See the Price Targets and Ratings of:

MEDS Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Trxade
Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MEDS Stock 12 Month Forecast

There Are No Analyst Ratings for MEDS In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MEDS Financial Forecast

MEDS Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

MEDS Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
EF Hutton
$18.75
Buy
83.11%
Upside
Initiated
05/31/23
Trxade Health assumed with a Buy at EF HuttonTrxade Health assumed with a Buy at EF Hutton
JMP Securities
$18.75
Buy
83.11%
Upside
Reiterated
05/16/23
Maxim Group
$15.00
Buy
46.48%
Upside
Reiterated
05/16/23

Best Analysts Covering Trxade Group

Which Analyst Should I Follow If I Want to Buy MEDS and Sell After:
1 Month
Allen KleeMaxim Group
Success Rate
3/11 ratings generated profit
27%
Average Return
-11.68%
reiterated a buy rating 11 months ago
Copying Allen Klee's trades and holding each position for 1 Month would result in 27.27% of your transactions generating a profit, with an average return of -11.68% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Allen KleeMaxim Group
Success Rate
4/11 ratings generated profit
36%
Average Return
-9.25%
reiterated a buy rating 11 months ago
Copying Allen Klee's trades and holding each position for 3 Months would result in 36.36% of your transactions generating a profit, with an average return of -9.25% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Allen KleeMaxim Group
Success Rate
2/11 ratings generated profit
18%
Average Return
-19.25%
reiterated a buy rating 11 months ago
Copying Allen Klee's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -19.25% per trade.
2 Years
Allen KleeMaxim Group
Success Rate
3/11 ratings generated profit
27%
Average Return
-14.53%
reiterated a buy rating 11 months ago
Copying Allen Klee's trades and holding each position for 2 Years would result in 27.27% of your transactions generating a profit, with an average return of -14.53% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MEDS Analyst Recommendation Trends

Rating
May 22
Jul 22
Nov 22
Mar 23
May 23
Strong Buy
0
1
2
3
5
Buy
3
2
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
5
In the current month, MEDS has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MEDS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MEDS Stock Forecast FAQ

What is MEDS’s average 12-month price target, according to analysts?
Currently, no data Available
What is MEDS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MEDS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is MEDS a Buy, Sell or Hold?
      Currently, no data Available
      What is Trxade Group’s price target?
      Currently, no data Available
      What do analysts say about Trxade Group?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of MEDS?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis